U.S. FDA Authorizes Novavax's COVID Vaccine As Booster for Adults
Oct 19 (Reuters) - The U.S. Food and Drug Administration on Wednesday authorized Novavax Inc's(NVAX.
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial